HEADER LIPID BINDING PROTEIN 23-JUL-15 5CSD TITLE LIGAND BINDING DOMAIN 2 OF PENICILLIUM MARNEFFEI MP1 PROTEIN IN TITLE 2 COMPLEX WITH ARACHIDONIC ACIDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE GLYCOPROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 187-345; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TALAROMYCES MARNEFFEI PM1; SOURCE 3 ORGANISM_TAXID: 1077442; SOURCE 4 GENE: GQ26_0022220; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: HIS-SUMO KEYWDS ARACHIDONIC ACID, LIGAND BINDING DOMAIN, LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR W.H.LAM,H.ZHANG,Q.HAO REVDAT 4 20-MAR-24 5CSD 1 REMARK REVDAT 3 08-MAR-17 5CSD 1 JRNL REVDAT 2 01-FEB-17 5CSD 1 JRNL REVDAT 1 27-JUL-16 5CSD 0 JRNL AUTH K.H.SZE,W.H.LAM,H.ZHANG,Y.H.KE,M.K.TSE,P.C.WOO,S.K.LAU, JRNL AUTH 2 C.C.LAU,J.P.CAI,E.T.TUNG,R.K.LO,S.XU,R.Y.KAO,Q.HAO,K.Y.YUEN JRNL TITL TALAROMYCES MARNEFFEI MP1P IS A VIRULENCE FACTOR THAT BINDS JRNL TITL 2 AND SEQUESTERS A KEY PROINFLAMMATORY LIPID TO DAMPEN HOST JRNL TITL 3 INNATE IMMUNE RESPONSE JRNL REF CELL CHEM BIOL V. 24 182 2017 JRNL REFN ESSN 2451-9456 JRNL PMID 28111099 JRNL DOI 10.1016/J.CHEMBIOL.2016.12.014 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 95019 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4995 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4741 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 657 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.24000 REMARK 3 B22 (A**2) : 0.14000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.075 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.073 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.049 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.539 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5CSD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000211163. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 100087 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.30300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.2.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM ACETATE, AMMONIUM REMARK 280 ACETATE, PH 4.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 29.25100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.02600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 29.25100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 50.02600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH D 410 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 160 REMARK 465 ALA B 160 REMARK 465 ALA C 160 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN D 23 OE1 GLN D 82 1.65 REMARK 500 ND2 ASN D 23 O HOH D 301 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 137 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 LYS B 119 CD - CE - NZ ANGL. DEV. = -19.9 DEGREES REMARK 500 ASP C 53 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 LYS C 149 CD - CE - NZ ANGL. DEV. = -14.4 DEGREES REMARK 500 ASP D 43 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP D 53 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 458 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH A 459 DISTANCE = 5.96 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL C 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL D 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD D 201 REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THE GENEBANK ACCESSION NUMBER KFX52825 IS FOR REMARK 999 THIS SEQUENCE. DBREF1 5CSD A 2 160 UNP A0A093VKV7_PENMA DBREF2 5CSD A A0A093VKV7 187 345 DBREF1 5CSD B 2 160 UNP A0A093VKV7_PENMA DBREF2 5CSD B A0A093VKV7 187 345 DBREF1 5CSD C 2 160 UNP A0A093VKV7_PENMA DBREF2 5CSD C A0A093VKV7 187 345 DBREF1 5CSD D 2 160 UNP A0A093VKV7_PENMA DBREF2 5CSD D A0A093VKV7 187 345 SEQRES 1 A 159 THR LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL SEQRES 2 A 159 ILE GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL SEQRES 3 A 159 ASP ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU SEQRES 4 A 159 LEU ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP SEQRES 5 A 159 GLY VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER SEQRES 6 A 159 MET GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SEQRES 7 A 159 SER ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP SEQRES 8 A 159 LYS LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS SEQRES 9 A 159 VAL GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN SEQRES 10 A 159 LYS LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU SEQRES 11 A 159 LEU ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA SEQRES 12 A 159 ALA GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR SEQRES 13 A 159 GLY PRO ALA SEQRES 1 B 159 THR LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL SEQRES 2 B 159 ILE GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL SEQRES 3 B 159 ASP ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU SEQRES 4 B 159 LEU ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP SEQRES 5 B 159 GLY VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER SEQRES 6 B 159 MET GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SEQRES 7 B 159 SER ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP SEQRES 8 B 159 LYS LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS SEQRES 9 B 159 VAL GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN SEQRES 10 B 159 LYS LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU SEQRES 11 B 159 LEU ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA SEQRES 12 B 159 ALA GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR SEQRES 13 B 159 GLY PRO ALA SEQRES 1 C 159 THR LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL SEQRES 2 C 159 ILE GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL SEQRES 3 C 159 ASP ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU SEQRES 4 C 159 LEU ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP SEQRES 5 C 159 GLY VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER SEQRES 6 C 159 MET GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SEQRES 7 C 159 SER ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP SEQRES 8 C 159 LYS LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS SEQRES 9 C 159 VAL GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN SEQRES 10 C 159 LYS LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU SEQRES 11 C 159 LEU ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA SEQRES 12 C 159 ALA GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR SEQRES 13 C 159 GLY PRO ALA SEQRES 1 D 159 THR LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL SEQRES 2 D 159 ILE GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL SEQRES 3 D 159 ASP ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU SEQRES 4 D 159 LEU ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP SEQRES 5 D 159 GLY VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER SEQRES 6 D 159 MET GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SEQRES 7 D 159 SER ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP SEQRES 8 D 159 LYS LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS SEQRES 9 D 159 VAL GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN SEQRES 10 D 159 LYS LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU SEQRES 11 D 159 LEU ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA SEQRES 12 D 159 ALA GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR SEQRES 13 D 159 GLY PRO ALA HET ACD A 201 22 HET ACD A 202 22 HET ACD B 201 22 HET ACD B 202 22 HET GOL C 200 6 HET ACD C 201 22 HET GOL D 200 6 HET ACD D 201 22 HETNAM ACD ARACHIDONIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 ACD 6(C20 H32 O2) FORMUL 9 GOL 2(C3 H8 O3) FORMUL 13 HOH *657(H2 O) HELIX 1 AA1 ILE A 8 TYR A 32 1 25 HELIX 2 AA2 ALA A 37 GLN A 59 1 23 HELIX 3 AA3 SER A 65 LYS A 93 1 29 HELIX 4 AA4 LYS A 93 ALA A 100 1 8 HELIX 5 AA5 PHE A 102 THR A 126 1 25 HELIX 6 AA6 PRO A 129 GLU A 131 5 3 HELIX 7 AA7 LEU A 132 ALA A 155 1 24 HELIX 8 AA8 ILE B 8 TYR B 32 1 25 HELIX 9 AA9 ALA B 37 GLN B 59 1 23 HELIX 10 AB1 SER B 65 LYS B 93 1 29 HELIX 11 AB2 LYS B 93 ALA B 100 1 8 HELIX 12 AB3 PHE B 102 THR B 126 1 25 HELIX 13 AB4 PRO B 129 GLU B 131 5 3 HELIX 14 AB5 LEU B 132 ALA B 155 1 24 HELIX 15 AB6 ILE C 8 TYR C 32 1 25 HELIX 16 AB7 ALA C 37 GLN C 59 1 23 HELIX 17 AB8 SER C 65 LYS C 93 1 29 HELIX 18 AB9 LYS C 93 ALA C 100 1 8 HELIX 19 AC1 PHE C 102 THR C 126 1 25 HELIX 20 AC2 PRO C 129 ALA C 155 1 27 HELIX 21 AC3 ILE D 8 TYR D 32 1 25 HELIX 22 AC4 ALA D 37 GLN D 59 1 23 HELIX 23 AC5 SER D 65 LYS D 93 1 29 HELIX 24 AC6 LYS D 93 ALA D 100 1 8 HELIX 25 AC7 PHE D 102 THR D 126 1 25 HELIX 26 AC8 PRO D 129 ALA D 155 1 27 SITE 1 AC1 13 LEU A 47 THR A 51 ILE A 83 ASN A 109 SITE 2 AC1 13 GLN A 113 ALA A 117 LEU A 120 SER A 121 SITE 3 AC1 13 VAL A 124 SER A 140 ILE A 147 ACD A 202 SITE 4 AC1 13 HOH A 333 SITE 1 AC2 10 LEU A 64 VAL A 76 LEU A 79 VAL A 124 SITE 2 AC2 10 VAL A 128 SER A 136 LEU A 139 SER A 140 SITE 3 AC2 10 ILE A 143 ACD A 201 SITE 1 AC3 14 LEU B 47 THR B 51 ILE B 83 ILE B 87 SITE 2 AC3 14 LEU B 90 ASN B 109 GLN B 113 ALA B 117 SITE 3 AC3 14 LEU B 120 SER B 121 VAL B 124 SER B 140 SITE 4 AC3 14 ILE B 147 ACD B 202 SITE 1 AC4 11 PHE B 11 LEU B 64 VAL B 76 LEU B 79 SITE 2 AC4 11 VAL B 124 VAL B 128 SER B 136 LEU B 139 SITE 3 AC4 11 SER B 140 ACD B 201 LEU C 70 SITE 1 AC5 10 LEU B 52 GLU B 115 ALA B 116 LYS B 119 SITE 2 AC5 10 HOH B 363 LEU C 52 GLN C 112 GLU C 115 SITE 3 AC5 10 ALA C 116 LYS C 119 SITE 1 AC6 4 ILE C 15 LEU C 47 THR C 51 GLN C 113 SITE 1 AC7 10 LEU A 52 GLU A 115 ALA A 116 LYS A 119 SITE 2 AC7 10 HOH A 366 LEU D 52 GLN D 112 GLU D 115 SITE 3 AC7 10 ALA D 116 LYS D 119 SITE 1 AC8 6 PHE D 11 ILE D 15 LEU D 47 THR D 51 SITE 2 AC8 6 GLN D 113 HOH D 304 CRYST1 58.502 100.052 99.050 90.00 90.01 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017093 0.000000 0.000003 0.00000 SCALE2 0.000000 0.009995 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010096 0.00000